The use of 1-aminocyclohexane derivatives to modify...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01)

Patent

CA 2540921

The invention relates to the use of NMDA receptor antagonists such as 1- aminocyclohexane derivatives to modify deposition of potentially toxic and fibrillogenic A.szlig. peptides in amyloidopathies. Specifically, the invention relates to the ability of memantine to intervene in the processing of APP and decrease the levels of fibrillogenic A.szlig. peptides.

L'invention se rapporte à l'utilisation d'antagonistes des récepteurs NMDA, tels que des dérivés de 1-aminocyclohexane, pour modifier le dépôt de peptides A.beta. fibrillogènes et potentiellement toxiques dans des amyloïdopathies. L'invention se rapporte spécifiquement à la capacité de la mémantine à jouer un rôle dans le traitement de l'APP et à réduire les taux de peptides A.beta. fibrillogènes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

The use of 1-aminocyclohexane derivatives to modify... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with The use of 1-aminocyclohexane derivatives to modify..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and The use of 1-aminocyclohexane derivatives to modify... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1724811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.